BIOASTER
Adrien Saliou has a diverse work experience in the fields of molecular biology, genomics, and microbiology. Adrien started their career as a Junior Research Scientist in Microbiology at Harvard Medical School, where they studied the CRISPR system. Adrien then worked as a PhD Student in Immunology and Infectious Diseases at INSERM U1043 - CPTP, developing virological tools to characterize HIV-1 resistance mechanisms. Adrien later joined Institut Curie as a Postdoctoral Fellow in Oncology, focusing on oncology research. In 2015, they joined BIOASTER as a Senior Scientist, Molecular Biology and NGS, where they developed new molecular techniques and managed R&D projects. Adrien also served as the Genomics and Transcriptomics Team Leader and is currently the Head of the OMICS Unit at BIOASTER. Additionally, Adrien co-founded KRIOYA, a Peruvian street food company, in 2019.
Adrien Saliou completed their education with a Doctor of Philosophy - PhD in immunology and infectious diseases from Université Paul Sabatier Toulouse III from 2009 to 2013. Prior to that, they pursued an Engineer in Biotechnology degree from Ecole Supérieure Biotechnologie Strasbourg - Universités de Strasbourg, Freiburg, Karlsruhe, Basel from 2006 to 2009. Adrien also attended Classes Préparatoires aux Grandes Ecoles, specializing in Physics & Chemistry, from 2003 to 2006.
BIOASTER
1 followers
BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures. BIOASTER, an independent non-profit organization, is one of 8 French TRIs created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions. Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries. More information on www.bioaster.org